Know Cancer

or
forgot password
  • cancer clinical trials in marietta, GA

  • Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Kidney Cancer
    Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
    Northwest Georgia Oncology Centers, P.C.
    Marietta, Georgia 30060
    Acinar Cell Carcinoma of Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Pancreatic Carcinoma Recurrent, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Pancreatic Carcinoma Stage III
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Breast Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Georgia Cancer Specialist

    Trial Locations
    Georgia Cancer Specialist
    Northwest Georgia Oncology Centers, PC
    Chronic Myeloid Leukemia
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Urology Enterprises
    Marietta, Georgia 30060
    Prostatic Neoplasms
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Northwest Georgia Oncology Centers, P.C.

    Trial Locations
    Northwest Georgia Oncology Centers, P.C.
    Urology Enterprises
    Georgia Cancer Specialists - Kennestone
    Advanced Prostate Cancer, Prostatic Neoplasms
    Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer
    Northwest Georgia Oncology Centers, P.C.
    Marietta, Georgia 30060
    Estrogen Receptor Positive Tumor, Breast Cancer
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Advanced Breast Care
    Marietta, Georgia 30060
    Breast Cancer
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Northwest Georgia Oncology Centers, P.C.
    Marietta, Georgia 30060
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Melanoma (Skin)
    Eflornithine in Treating Patients With Bladder Cancer
    Urology Associates, Inc.
    Marietta, Georgia 30060
    Bladder Cancer
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    Clinical Trial in Males With BPH (Enlarged Prostate)
    Urology Associates
    Marietta, Georgia 30060
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Lung Cancer
    EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Breast Cancer, Neurotoxicity
    Prialt (Ziconotide) In Severe Chronic Pain
    Georgia Medical Research Institute
    Marietta, Georgia 30060
    Pain
    S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Leukemia
    Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    Georgia Oncology Partners Research & Education Foundation
    Marietta, Georgia 30060
    Non-small Cell Lung Cancer
    Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Breast Cancer, Osteoporosis
    Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
    Northwest Georgia Oncology - Wellstar Cancer Research
    Marietta, Georgia 30060
    Myelodysplastic Syndromes
    Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
    Northwest Georgia Oncology - Wellstar Cancer Research
    Marietta, Georgia 30060
    Myelodysplastic Syndromes
    Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
    Northwest Georgia Oncology Centers
    Marietta, Georgia 30060
    Multiple Myeloma
    S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Sarcoma
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    Comprehensive Pain Care, PC
    Marietta, Georgia 30060
    Pain
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Lung Cancer
    A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
    WellStar Cancer Research Office
    Marietta, Georgia 30060
    Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Esophageal Cancer
    The Plenaxis® Experience Study
    Urology Associates, P.C.
    Marietta, Georgia 30060
    Prostate Cancer
    Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
    Center for Prospective Outcome
    Marietta, Georgia 30060
    Pain, Cancer
    ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Breast Cancer
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Lymphoma
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Urology Enterprises
    Marietta, Georgia 30060
    Prostate Cancer, Osteoporosis, Fractures
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Wellstar Cancer Research
    Marietta, Georgia 30060
    Neoplasms, Unknown Primary
    Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Lung Cancer
    Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
    Northwest Georgia Oncology Centers, PC
    Marietta, Georgia 30060
    Breast Neoplasm
    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
    Northwest Georgia Oncology Centers, PC
    Marietta, Georgia 30060
    Breast Neoplasms, Neoplasm Metastasis
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
    Wellstar Cancer Research
    Marietta, Georgia 30060
    Rectal Cancer, Cancer of the Rectum, Colorectal Cancer
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Northwest Georgia Oncology Centers, P.C.
    Marietta, Georgia 30060
    Non-Hodgkin's Lymphoma
    Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma
    Northwest Georgia Oncology Centers, PC
    Marietta, Georgia 30060
    Multiple Myeloma
    Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular NHL
    Wellstar-Northwest Georgia Oncology Centers
    Marietta, Georgia 30060
    Follicular Lymphoma, Lymphoma, Follicular
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Kennestone Cancer Center at Wellstar Kennestone Hospital
    Marietta, Georgia 30060
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer
    NorthWest Georgia Oncology Centers Marietta Center
    Marietta, Georgia 30060
    Metastatic Hormone Refractory Prostate Cancer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Wellstar Cardiovascular Medicine, Pc
    Marietta, Georgia 30060
    Atrial Fibrillation, Atrial Flutter
    Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
    Northwest Georgia Oncology Centers
    Marietta, Georgia 30060
    Myelodysplastic Syndromes
    A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
    Northwest Georgia Oncology Centers, PC., Wellstar Health System
    Marietta, Georgia 30060
    Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic
    Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)
    Northwest Georgia Oncology Centers
    Marietta, Georgia 30060
    Metastatic Prostate Cancer
    First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
    Wellstar Cancer Research
    Marietta, Georgia 30060
    Lung Cancer
    A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Northwest Georgia Oncology Centers
    Marietta, Georgia 30060
    Diffuse Large B-cell Lymphoma
    Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC
    Northwest Georgia Oncology Center
    Marietta, Georgia 30060
    Non-Small Cell Lung Cancer
    Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
    Northwest Georgia Oncology Centers
    Marietta, Georgia 30060
    Renal Cell Carcinoma
    Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Wellstar Cancer Research
    Marietta, Georgia 30060
    Non-Small Cell Lung Cancer